Search results
Author(s):
Added:
1 month ago
Dr Amr Nawar (Sultan Qaboos University Hospital, Muscat, OM) walks through a concomitant pulmonary vein isolation (PVI) and left atrial appendage (LAA) closure procedure in a single 90-minute session — treating the arrhythmia and addressing embolic risk simultaneously.The case centres on a 70-year-old male with atrial fibrillation and a history of two transient ischaemic attacks. Dr Nawar details…
View more
Author(s):
Devi Nair
Added:
3 months ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented…
View more
Author(s):
Roland R Tilz
Added:
3 months ago
AF Symposium 2026 - Prof Roland Tilz (University Heart Center Lübeck, DE) presents updated findings from the STYLE AF study evaluating vascular closure strategies in patients undergoing atrial fibrillation ablation, with implications for procedural efficiency and same-day discharge protocols.Results demonstrated clear superiority of the vascular closure device across multiple clinically relevant…
View more
Author(s):
Roland R Tilz
Added:
2 years ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125…
View more
Author(s):
Walid Saliba
Added:
1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and…
View more
Author(s):
Saibal Kar
,
Harriette Van Spall
Added:
1 month ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk…
View more
Author(s):
Devi Nair
,
Vivek Reddy
Added:
1 month ago
ACC.26 - At ACC.26 in New Orleans, Dr Devi Nair (Arkansas, US) and Dr Vivek Reddy (New York, US) dissect the late-breaking CHAMPION‑AF trial, a large randomized comparison of first-line left atrial appendage closure with WATCHMAN FLX versus continued NOAC therapy in patients with non-valvular AF who can tolerate anticoagulation. They review the trial design, post‑implant antithrombotic and…
View more
Author(s):
Karim Al-Azizi
,
Devi Nair
,
Added:
1 week ago
In this expert discussion, DrKarim Al-Azizi(Baylor Scott & White The Heart Hospital, US), Editor-in-Chief of the Transcatheter Academy, is joined by steering committee members DrDevi Nair(Chief VP of Research, Arkansas Heart Hospital, US) and DrMegan Coylewright(Essentia Health, US) to unpack the landmark CHAMPION-AF trial (NCT05964200) and its implications for stroke prevention in atrial…
View more
EHRA 2024: Late-Breaking Science Video Collection
Author(s):
Laurent Fiorina
Added:
2 years ago
Video Series
Douglas Muir
Job title: Consultant Interventional Cardiologist
Author